Description
The module provides an overview of basic scientific concepts that underpin development of novel immunotherapeutic approaches including gene and cell therapy, checkpoint inhibitors and biologics. In addition, students will learn about regulatory aspects, which are required to help make future medicinal products safe and effective. In particular, the content will include discussion of different types of cell therapy, viral vectors, gene editing, tissue engineering and checkpoint therapies in the context of immune deficiency, cancer and autoimmune disease.
Aims
To provide students with a good understanding of biological basis and current clinical applications of novel immune therapies
In particular the aims of the module are:
- To provide students with up to date knowledge and understanding of scientific concepts that underpin current immunotherapeutic approaches
- To describe key techniques/ methodologies at the forefront of novel immunological therapies
- To make students aware of ethical and regulatory considerations of these approaches
Learning outcomes
The students will be able to:
- Examine and discuss immunological therapies from basic scientific concepts through to current and future therapeutic application
- Compare, contrast and appraise key methodologies and approaches in the development of novel therapeutics
- Evaluate and critically appraise key data that informs development of novel therapies
- Discuss ethical and regulatory consideration related to immune therapeutics
Module deliveries for 2024/25 academic year
Last updated
This module description was last updated on 19th August 2024.
Ìý